SlideShare a Scribd company logo
Essential Framework for Compliance in Technical Documentation Under MDR
(EU) 2017/745
The European Union's Medical Device Regulation (EU) 2017/745 mandates
extensive technical documentation to demonstrate the safety, quality, and
performance of medical devices. Manufacturers should prepare and maintain
this documentation throughout the entire lifecycle of the device to ensure
compliance with the stringent regulatory requirements. It serves as critical
evidence of compliance and is essential for CE marking and continued market
access.
The essential aspects of technical documentation required under the MDR
 Technical documentation serves as a structured repository of information
demonstrating that a medical device meets regulatory, safety, and
performance requirements. It allows Notified Bodies, Competent
Authorities, and other stakeholders to assess the conformity of a device.
 Technical documentation demonstrates how the device satisfies every
applicable General Safety and Performance Requirements (GSPRs) outlined
in Annex I of the MDR. The documentation presents evidence of compliance
with design, manufacturing, performance, and safety.
 Improved traceability comes through deploying the Unique Device
Identification (UDI) system. Using UDI, most of the details about implanted
devices are opened up to the benefit of patients in terms of understanding
and trust. Besides UDI, another critical aspect of tracking adverse events
includes improving understanding of the performance of devices in actual
settings to make better and, ultimately, safer devices.
 A well-structured technical documentation guarantees a seamless
conformity assessment process with the Notified Body and acts as the
primary evidence to prove the device complies with CE marking standards.
Regulation 2017/745 mandates manufacturers to carry out post-market
surveillance (PMS) that includes PMS plans, PMS Reports (PMSR) or Periodic
Safety Update Reports (PSUR), Post-market Clinical Follow-up (PMCF) data,
and vigilance systems supporting ongoing compliance.
 During inspections or audits, Notified Body and Regulatory authorities may
request access to technical documentation. Comprehensive and organized
documentation facilitates efficient review processes.
 Manufacturers cannot apply the CE mark or legally market their devices
within the European Union without the technical documentation
Key Components of Technical Documentation under MDR
1. Device Description and Specification: It gives a precise overview of the
device, including its intended purpose, device's design, components,
materials, operating principles, and key technical specifications. It shall also
specify the target patient population, intended clinical indication, medical
condition, and any size variations, configurations, or features to
accommodate different needs or use cases.
2. Instructions for Use (IFU) and Labeling: It should provide clear, accurate,
and compliant information designed to guide end users in the safe and
effective use of the device. It should include the information required by the
applicable sections 23 of Annex I of Regulation (EU) 2017/745, The
information must be presented in a manner that is easily understandable to
the intended user group, including healthcare professionals or laypersons.
3. The Design and Manufacturing Information: These include the design
inputs and outputs, design controls, and any design changes made during
the design development stage. It specifies the raw materials sources,
properties, attributes, and compliance with regulatory standards. It outlines
the manufacturing processes in brief as well as via schematic
representation, including assembly methods, quality control measures, and
traceability procedures, ensuring the device consistently meets safety and
performance standards.
4. GSPR Checklist: It provides documented evidence of the device's
compliance with the General Safety and Performance Requirements (GSPR)
outlined in Annex I of Regulation (EU) 2017/745. This checklist provides a
systematic reference to the provisions of each of these requirements in the
technical documentation that illustrates conformity.
5. Benefit-Risk Analysis and Risk Management: It provides a comprehensive
record of the risk management activities carried out for the device,
considering the requirements of ISO 14971 and ISO/TR 24971. It includes an
identification of risks in the device lifecycle using risk analysis, and assess
the severity and likelihood of potential hazards. This also contains the
mitigation strategies and controls that bring the risks to acceptable levels,
followed by proof of the efficacy of the mitigation strategies and controls.
6. Product Verification and Validation: To ensure safety with use of device,
Pre-Clinical & Clinical Data which includes engineering, laboratory, simulated
use, and animal studies, Biocompatibility (in-vivo and in-vitro studies),
chemical/physical properties, electrical safety, software validation, stability
(shelf life), and overall performance must be tested.
Clinical Evaluation Report (CER): CER documents the device's clinical safety
and performance through robust clinical data. It analyzes evidence from pre-
market investigations, post-market surveillance, scientific literature, and
equivalent devices. The report outlines the entire evaluation process,
addresses all identified risks, confirms the safety in achieving the device’s
intended purpose safely, provides conclusions on its benefit-risk profile, and
ensures compliance with Regulation (EU) 2017/745.
Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up
(PMCF): PMS under MDR (EU) 2017/745 mandates manufacturers to
continuously monitor device performance and safety after they are put on
the market. PMS systems must be proactive, systematic, and documented,
ensuring compliance with Annex III. PMCF is a key part of PMS, collecting
real-world clinical data to confirm safety, performance, and risk-benefit
balance. PMCF studies identify emerging risks, support risk management,
and update clinical evaluations. Regular Periodic Safety Update Reports
(PSURs) and PMS Reports ensure ongoing regulatory compliance and
patient safety.
Summary of Safety and Clinical Performance: SSCP ensures transparency
by providing objective and evidence-based information on medical device
safety and clinical performance under MDR (EU) 2017/745, Article 32 for
class III and implantable devices. The device description, intended use, risk-
benefit analysis, clinical evaluation outcomes, and post-market surveillance
data are all included in the SSCP. By empowering healthcare professionals
and, when appropriate, patients to make informed decisions, it enhances
regulatory compliance rather than taking the role of the instructions for use
(IFU).
 Conclusion
MDR compliance hinges on robust technical documentation, a non-negotiable
requirement for every manufacturer seeking CE marking and continued access to
the European market. This documentation plays a crucial role in ensuring that only
safe and effective medical devices are available to patients and intended users.
Therefore, manufacturers must prioritize investing the necessary time and
resources to create comprehensive and compliant technical documentation.
Author
Mrs. Kirti Salunke, (M.Pharm)
Team Lead -Medical Device Consultant

More Related Content

DOCX
Preparing for Notified Body Scrutiny of PMCF.docx
PDF
Clinical Evaluation Report for Medical Devices
PDF
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
DOCX
The Role of Post Market Surveillance Data in Clinical Evaluation Reports.docx
PDF
The Key Components of a Successful Clinical Evaluation Report under MDR 2017 ...
PDF
Navigating Clinical Evaluation Process for Combination Products.pdf
DOCX
Regulatory Approaches for Implantable Medical Devices Exploring EU MDR.docx
DOCX
Regulatory Approaches for Implantable Medical Devices Exploring EU MDR.docx
Preparing for Notified Body Scrutiny of PMCF.docx
Clinical Evaluation Report for Medical Devices
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
The Role of Post Market Surveillance Data in Clinical Evaluation Reports.docx
The Key Components of a Successful Clinical Evaluation Report under MDR 2017 ...
Navigating Clinical Evaluation Process for Combination Products.pdf
Regulatory Approaches for Implantable Medical Devices Exploring EU MDR.docx
Regulatory Approaches for Implantable Medical Devices Exploring EU MDR.docx

Similar to Technical Documentation Compliance Final.docx (20)

PDF
Clinical Evaluation and Labelling: How They Are Interlinked
DOCX
Regulatory Considerations for Active Implantable Medical Devices (AIMDs)
PDF
The EU’s Medical Device Regulation
PDF
Educo Life Science [gathering clinical evidence] [module 1]
PDF
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
PDF
20210413 nvfg acs iso14155 13_apr2021
PDF
Post Marketing Surveillance - RSI
DOCX
Art 4 General principles of Claiming Equivalence under the MDR.docx
DOCX
AtharBuchheitHussein-A3-EU PLAN REGULATORY STRATEGY
PPTX
mHealth Israel_EU MedTech and eHealth Regulatory Framework
PDF
Understanding Post-market Surveillance under EU MDR: Being Proactive, not Rea...
PPTX
EU MDR
PDF
clinical-evaluation-report (CER)
PPTX
Medical Devices Regulation (MDR) 2017/745 - Part II Placing devices on EU ma...
PPTX
DEVICE MASTER FILE - as per Medical device Rules 2017
PPTX
DEVICE MASTER FILE as per Indian Medical device Rules 2017
DOCX
Understanding the Systems and Procedure Packs.docx
PPTX
Technical Files for Medical Devices
PPTX
Technical Files for Medical Devices
PDF
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Clinical Evaluation and Labelling: How They Are Interlinked
Regulatory Considerations for Active Implantable Medical Devices (AIMDs)
The EU’s Medical Device Regulation
Educo Life Science [gathering clinical evidence] [module 1]
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
20210413 nvfg acs iso14155 13_apr2021
Post Marketing Surveillance - RSI
Art 4 General principles of Claiming Equivalence under the MDR.docx
AtharBuchheitHussein-A3-EU PLAN REGULATORY STRATEGY
mHealth Israel_EU MedTech and eHealth Regulatory Framework
Understanding Post-market Surveillance under EU MDR: Being Proactive, not Rea...
EU MDR
clinical-evaluation-report (CER)
Medical Devices Regulation (MDR) 2017/745 - Part II Placing devices on EU ma...
DEVICE MASTER FILE - as per Medical device Rules 2017
DEVICE MASTER FILE as per Indian Medical device Rules 2017
Understanding the Systems and Procedure Packs.docx
Technical Files for Medical Devices
Technical Files for Medical Devices
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Ad

More from I3CGLOBAL (20)

PDF
Health Canada Medical Device Approval Services by I3CGlobal – Your Trusted Re...
PPTX
FDA Device Registration and Listing.pptx
PDF
US FDA Pre-inspection Facility And Documentation Gap Assessment
DOCX
The Impact of Brexit and MDR on Manufacturers.docx
DOCX
US FDA Aspects of IVD Instrument its Components, Regulatory Framework and Key...
DOCX
Risk Management and Risk Analysis Techniques for IVD and Non IVD Medical Devi...
DOCX
Understanding FDA Management of Medical Device Recalls and Safety Alerts.docx
DOCX
The Significance of of UDI for Medical Device Regulation.docx
DOCX
Key Design Considerations and FDA 510k Pre-Market Submission Guidelines for I...
DOCX
Key Considerations For Drafting Benefit-Risk Analysis In FDA 510k Medical Dev...
DOCX
Artificial Intelligence In Regulatory Compliance.docx
DOCX
USFDA aspects of In Vitro Diagnostic Systems in Modern Healthcare.docx
DOCX
Cybersecurity for Active Implantable Medical Devices.docx
DOCX
Handling Legacy Devices Under IVDR: Consultant's Role
DOCX
THE ROLE OF VIGILANCE REPORTING IN ENSURING EU MDR COMPLIANCE.docx
DOCX
Key Differences Between EU MDR and MDD in Demonstrating Equivalence of Medica...
DOCX
Ethylene Oxide (ETO) Sterilization Ensuring Medical Device Safety and Complia...
DOCX
Software Medical Device Documentation for 510(k) Submissions.docx
DOCX
Medical Device Labeling: A Key Requirement For 510k.docx
DOCX
NGS IVDs: FDA 510(k) Regulatory Considerations for Genomic Diagnostics
Health Canada Medical Device Approval Services by I3CGlobal – Your Trusted Re...
FDA Device Registration and Listing.pptx
US FDA Pre-inspection Facility And Documentation Gap Assessment
The Impact of Brexit and MDR on Manufacturers.docx
US FDA Aspects of IVD Instrument its Components, Regulatory Framework and Key...
Risk Management and Risk Analysis Techniques for IVD and Non IVD Medical Devi...
Understanding FDA Management of Medical Device Recalls and Safety Alerts.docx
The Significance of of UDI for Medical Device Regulation.docx
Key Design Considerations and FDA 510k Pre-Market Submission Guidelines for I...
Key Considerations For Drafting Benefit-Risk Analysis In FDA 510k Medical Dev...
Artificial Intelligence In Regulatory Compliance.docx
USFDA aspects of In Vitro Diagnostic Systems in Modern Healthcare.docx
Cybersecurity for Active Implantable Medical Devices.docx
Handling Legacy Devices Under IVDR: Consultant's Role
THE ROLE OF VIGILANCE REPORTING IN ENSURING EU MDR COMPLIANCE.docx
Key Differences Between EU MDR and MDD in Demonstrating Equivalence of Medica...
Ethylene Oxide (ETO) Sterilization Ensuring Medical Device Safety and Complia...
Software Medical Device Documentation for 510(k) Submissions.docx
Medical Device Labeling: A Key Requirement For 510k.docx
NGS IVDs: FDA 510(k) Regulatory Considerations for Genomic Diagnostics
Ad

Recently uploaded (20)

PPTX
ICG2025_ICG 6th steering committee 30-8-24.pptx
PDF
Solara Labs: Empowering Health through Innovative Nutraceutical Solutions
PDF
How to Get Funding for Your Trucking Business
DOCX
unit 2 cost accounting- Tender and Quotation & Reconciliation Statement
PDF
NewBase 12 August 2025 Energy News issue - 1812 by Khaled Al Awadi_compresse...
PPT
340036916-American-Literature-Literary-Period-Overview.ppt
PDF
Tata consultancy services case study shri Sharda college, basrur
PDF
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
PPTX
Amazon (Business Studies) management studies
PPTX
svnfcksanfskjcsnvvjknsnvsdscnsncxasxa saccacxsax
PPTX
Probability Distribution, binomial distribution, poisson distribution
PDF
Reconciliation AND MEMORANDUM RECONCILATION
PDF
Roadmap Map-digital Banking feature MB,IB,AB
PPTX
Belch_12e_PPT_Ch18_Accessible_university.pptx
PPTX
Principles of Marketing, Industrial, Consumers,
PPTX
3. HISTORICAL PERSPECTIVE UNIIT 3^..pptx
PDF
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
PPTX
New Microsoft PowerPoint Presentation - Copy.pptx
PPTX
HR Introduction Slide (1).pptx on hr intro
PDF
Unit 1 Cost Accounting - Cost sheet
ICG2025_ICG 6th steering committee 30-8-24.pptx
Solara Labs: Empowering Health through Innovative Nutraceutical Solutions
How to Get Funding for Your Trucking Business
unit 2 cost accounting- Tender and Quotation & Reconciliation Statement
NewBase 12 August 2025 Energy News issue - 1812 by Khaled Al Awadi_compresse...
340036916-American-Literature-Literary-Period-Overview.ppt
Tata consultancy services case study shri Sharda college, basrur
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
Amazon (Business Studies) management studies
svnfcksanfskjcsnvvjknsnvsdscnsncxasxa saccacxsax
Probability Distribution, binomial distribution, poisson distribution
Reconciliation AND MEMORANDUM RECONCILATION
Roadmap Map-digital Banking feature MB,IB,AB
Belch_12e_PPT_Ch18_Accessible_university.pptx
Principles of Marketing, Industrial, Consumers,
3. HISTORICAL PERSPECTIVE UNIIT 3^..pptx
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
New Microsoft PowerPoint Presentation - Copy.pptx
HR Introduction Slide (1).pptx on hr intro
Unit 1 Cost Accounting - Cost sheet

Technical Documentation Compliance Final.docx

  • 1. Essential Framework for Compliance in Technical Documentation Under MDR (EU) 2017/745 The European Union's Medical Device Regulation (EU) 2017/745 mandates extensive technical documentation to demonstrate the safety, quality, and performance of medical devices. Manufacturers should prepare and maintain this documentation throughout the entire lifecycle of the device to ensure compliance with the stringent regulatory requirements. It serves as critical evidence of compliance and is essential for CE marking and continued market access. The essential aspects of technical documentation required under the MDR  Technical documentation serves as a structured repository of information demonstrating that a medical device meets regulatory, safety, and performance requirements. It allows Notified Bodies, Competent Authorities, and other stakeholders to assess the conformity of a device.  Technical documentation demonstrates how the device satisfies every applicable General Safety and Performance Requirements (GSPRs) outlined in Annex I of the MDR. The documentation presents evidence of compliance with design, manufacturing, performance, and safety.  Improved traceability comes through deploying the Unique Device Identification (UDI) system. Using UDI, most of the details about implanted devices are opened up to the benefit of patients in terms of understanding and trust. Besides UDI, another critical aspect of tracking adverse events includes improving understanding of the performance of devices in actual settings to make better and, ultimately, safer devices.  A well-structured technical documentation guarantees a seamless conformity assessment process with the Notified Body and acts as the primary evidence to prove the device complies with CE marking standards. Regulation 2017/745 mandates manufacturers to carry out post-market surveillance (PMS) that includes PMS plans, PMS Reports (PMSR) or Periodic Safety Update Reports (PSUR), Post-market Clinical Follow-up (PMCF) data, and vigilance systems supporting ongoing compliance.  During inspections or audits, Notified Body and Regulatory authorities may request access to technical documentation. Comprehensive and organized documentation facilitates efficient review processes.  Manufacturers cannot apply the CE mark or legally market their devices within the European Union without the technical documentation
  • 2. Key Components of Technical Documentation under MDR 1. Device Description and Specification: It gives a precise overview of the device, including its intended purpose, device's design, components, materials, operating principles, and key technical specifications. It shall also specify the target patient population, intended clinical indication, medical condition, and any size variations, configurations, or features to accommodate different needs or use cases. 2. Instructions for Use (IFU) and Labeling: It should provide clear, accurate, and compliant information designed to guide end users in the safe and effective use of the device. It should include the information required by the applicable sections 23 of Annex I of Regulation (EU) 2017/745, The information must be presented in a manner that is easily understandable to the intended user group, including healthcare professionals or laypersons. 3. The Design and Manufacturing Information: These include the design inputs and outputs, design controls, and any design changes made during the design development stage. It specifies the raw materials sources, properties, attributes, and compliance with regulatory standards. It outlines the manufacturing processes in brief as well as via schematic representation, including assembly methods, quality control measures, and traceability procedures, ensuring the device consistently meets safety and performance standards. 4. GSPR Checklist: It provides documented evidence of the device's compliance with the General Safety and Performance Requirements (GSPR) outlined in Annex I of Regulation (EU) 2017/745. This checklist provides a systematic reference to the provisions of each of these requirements in the technical documentation that illustrates conformity. 5. Benefit-Risk Analysis and Risk Management: It provides a comprehensive record of the risk management activities carried out for the device, considering the requirements of ISO 14971 and ISO/TR 24971. It includes an identification of risks in the device lifecycle using risk analysis, and assess the severity and likelihood of potential hazards. This also contains the mitigation strategies and controls that bring the risks to acceptable levels, followed by proof of the efficacy of the mitigation strategies and controls. 6. Product Verification and Validation: To ensure safety with use of device, Pre-Clinical & Clinical Data which includes engineering, laboratory, simulated use, and animal studies, Biocompatibility (in-vivo and in-vitro studies),
  • 3. chemical/physical properties, electrical safety, software validation, stability (shelf life), and overall performance must be tested. Clinical Evaluation Report (CER): CER documents the device's clinical safety and performance through robust clinical data. It analyzes evidence from pre- market investigations, post-market surveillance, scientific literature, and equivalent devices. The report outlines the entire evaluation process, addresses all identified risks, confirms the safety in achieving the device’s intended purpose safely, provides conclusions on its benefit-risk profile, and ensures compliance with Regulation (EU) 2017/745. Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF): PMS under MDR (EU) 2017/745 mandates manufacturers to continuously monitor device performance and safety after they are put on the market. PMS systems must be proactive, systematic, and documented, ensuring compliance with Annex III. PMCF is a key part of PMS, collecting real-world clinical data to confirm safety, performance, and risk-benefit balance. PMCF studies identify emerging risks, support risk management, and update clinical evaluations. Regular Periodic Safety Update Reports (PSURs) and PMS Reports ensure ongoing regulatory compliance and patient safety. Summary of Safety and Clinical Performance: SSCP ensures transparency by providing objective and evidence-based information on medical device safety and clinical performance under MDR (EU) 2017/745, Article 32 for class III and implantable devices. The device description, intended use, risk- benefit analysis, clinical evaluation outcomes, and post-market surveillance data are all included in the SSCP. By empowering healthcare professionals and, when appropriate, patients to make informed decisions, it enhances regulatory compliance rather than taking the role of the instructions for use (IFU).  Conclusion MDR compliance hinges on robust technical documentation, a non-negotiable requirement for every manufacturer seeking CE marking and continued access to the European market. This documentation plays a crucial role in ensuring that only safe and effective medical devices are available to patients and intended users. Therefore, manufacturers must prioritize investing the necessary time and resources to create comprehensive and compliant technical documentation. Author Mrs. Kirti Salunke, (M.Pharm)
  • 4. Team Lead -Medical Device Consultant